sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide

C113H154Br2N25NaO18 — CID 163813191

About sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide

sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide (PubChem CID 163813191) has the molecular formula C113H154Br2N25NaO18 and a molecular weight of 2333.43 g/mol. Its IUPAC name is sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide.

Molecular Properties

• Compound Name: sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide
• PubChem CID: 163813191
• Molecular Formula: C113H154Br2N25NaO18
• Molecular Weight: 2333.43 g/mol
• Exact Mass: 2330.02
• IUPAC Name: sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide
• SMILES: CC(C)(CO)Nc1cccc(NC(=O)c2ccc(NC(C)(C)CO)nc2N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1.CC1(C)COC(=O)N1c1ccc(C(=O)Nc2cccc(Br)n2)c(N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1c1ccc(C(=O)O)c(N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1c1cccc(NC(=O)c2ccc(N3C(=O)OCC3(C)C)nc2N2CCC3(CC2)CC3)n1.CN[C@@H]1CCCC[C@H]1NC.Nc1cccc(Br)n1.[Na+].[OH-]
• InChI: InChI=1S/C28H34N6O5.C26H38N6O3.C23H26BrN5O3.C18H23N3O4.C8H18N2.C5H5BrN2.C5H9NO2.Na.H2O/c1-26(2)16-38-24(36)33(26)20-7-5-6-19(29-20)30-23(35)18-8-9-21(34-25(37)39-17-27(34,3)4)31-22(18)32-14-12-28(10-11-28)13-15-32;1-24(2,16-33)30-20-7-5-6-19(27-20)29-23(35)18-8-9-21(31-25(3,4)17-34)28-22(18)32-14-12-26(10-11-26)13-15-32;1-22(2)14-32-21(31)29(22)18-7-6-15(20(30)26-17-5-3-4-16(24)25-17)19(27-18)28-12-10-23(8-9-23)11-13-28;1-17(2)11-25-16(24)21(17)13-4-3-12(15(22)23)14(19-13)20-9-7-18(5-6-18)8-10-20;1-9-7-5-3-4-6-8(7)10-2;6-4-2-1-3-5(7)8-4;1-5(2)3-8-4(7)6-5;;/h5-9H,10-17H2,1-4H3,(H,29,30,35);5-9,33-34H,10-17H2,1-4H3,(H,28,31)(H2,27,29,30,35);3-7H,8-14H2,1-2H3,(H,25,26,30);3-4H,5-11H2,1-2H3,(H,22,23);7-10H,3-6H2,1-2H3;1-3H,(H2,7,8);3H2,1-2H3,(H,6,7);;1H2/q;;;;;;;+1;/p-1/t;;;;7-,8-;;;;/m....1..../s1
• InChIKey: NPBLFSBWKXHEPS-ZGKUBPGLSA-M
• XLogP: 15.05
• TPSA: 541.77 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 34
• Rotatable Bonds: 23
• Heavy Atoms: 159
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2333.43
LogP ≤ 5	15.05
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide?

The IUPAC name of sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide (CID 163813191) is sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide.

What is the SMILES notation for sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide?

The canonical SMILES for sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide is CC(C)(CO)Nc1cccc(NC(=O)c2ccc(NC(C)(C)CO)nc2N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1.CC1(C)COC(=O)N1c1ccc(C(=O)Nc2cccc(Br)n2)c(N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1c1ccc(C(=O)O)c(N2CCC3(CC2)CC3)n1.CC1(C)COC(=O)N1c1cccc(NC(=O)c2ccc(N3C(=O)OCC3(C)C)nc2N2CCC3(CC2)CC3)n1.CN[C@@H]1CCCC[C@H]1NC.Nc1cccc(Br)n1.[Na+].[OH-].

What is the InChIKey of sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide?

The InChIKey is NPBLFSBWKXHEPS-ZGKUBPGLSA-M. The full InChI is InChI=1S/C28H34N6O5.C26H38N6O3.C23H26BrN5O3.C18H23N3O4.C8H18N2.C5H5BrN2.C5H9NO2.Na.H2O/c1-26(2)16-38-24(36)33(26)20-7-5-6-19(29-20)30-23(35)18-8-9-21(34-25(37)39-17-27(34,3)4)31-22(18)32-14-12-28(10-11-28)13-15-32;1-24(2,16-33)30-20-7-5-6-19(27-20)29-23(35)18-8-9-21(31-25(3,4)17-34)28-22(18)32-14-12-26(10-11-26)13-15-32;1-22(2)14-32-21(31)29(22)18-7-6-15(20(30)26-17-5-3-4-16(24)25-17)19(27-18)28-12-10-23(8-9-23)11-13-28;1-17(2)11-25-16(24)21(17)13-4-3-12(15(22)23)14(19-13)20-9-7-18(5-6-18)8-10-20;1-9-7-5-3-4-6-8(7)10-2;6-4-2-1-3-5(7)8-4;1-5(2)3-8-4(7)6-5;;/h5-9H,10-17H2,1-4H3,(H,29,30,35);5-9,33-34H,10-17H2,1-4H3,(H,28,31)(H2,27,29,30,35);3-7H,8-14H2,1-2H3,(H,25,26,30);3-4H,5-11H2,1-2H3,(H,22,23);7-10H,3-6H2,1-2H3;1-3H,(H2,7,8);3H2,1-2H3,(H,6,7);;1H2/q;;;;;;;+1;/p-1/t;;;;7-,8-;;;;/m....1..../s1.

What are the key properties of sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide?

sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide has a molecular weight of 2333.43 g/mol, XLogP of 15.05, 23 rotatable bonds, 12 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for sodium;2-(6-azaspiro[2.5]octan-6-yl)-N-(6-bromo-2-pyridinyl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-[6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-pyridinyl]pyridine-3-carboxamide;2-(6-azaspiro[2.5]octan-6-yl)-6-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)pyridine-3-carboxylic acid;2-(6-azaspiro[2.5]octan-6-yl)-6-[(1-hydroxy-2-methylpropan-2-yl)amino]-N-[6-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-pyridinyl]pyridine-3-carboxamide;6-bromopyridin-2-amine;4,4-dimethyl-1,3-oxazolidin-2-one;trans-(1R,2R)-1-N,2-N-dimethylcyclohexane-1,2-diamine;hydroxide is sourced from PubChem (CID 163813191), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).